Cardio Diagnostics Holdings Stock Analysis

Cardio Stock Analysis Notes

The book value of the company was currently reported as 0.21. The company recorded a loss per share of 0.31. Cardio Diagnostics had not issued any dividends in recent years. Cardio Diagnostics Inc. develops and manufactures a genetic and epigenetic based test for prevention and detection of cardiovascular disease. Cardio Diagnostics Inc. was founded in 2017 and is based in Chicago, Illinois. Cardio Diagnostics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. For more info on Cardio Diagnostics Holdings please contact Meeshanthini Dogan at 302 281 2147 or go to https://cardiodiagnosticsinc.com.

Cardio Diagnostics Investment Alerts

Cardio Diagnostics Upcoming and Recent Events

Cardio Largest EPS Surprises

View All Earnings Estimates

Cardio Stock Institutional Investors

Note, although Cardio Diagnostics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Cardio Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.3 M.

Cardio Profitablity

Management Efficiency

Cardio Diagnostics has return on total asset (ROA) of (0.6936) % which means that it has lost $0.6936 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3396) %, meaning that it created substantial loss on money invested by shareholders. Cardio Diagnostics' management efficiency ratios could be used to measure how well Cardio Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of March 2025, Return On Tangible Assets is likely to drop to -0.83. In addition to that, Return On Capital Employed is likely to drop to -0.88. At this time, Cardio Diagnostics' Total Assets are very stable compared to the past year. As of the 28th of March 2025, Net Tangible Assets is likely to grow to about 929.3 K, while Non Current Assets Total are likely to drop about 964.4 K.

Technical Drivers

As of the 28th of March, Cardio Diagnostics shows the Standard Deviation of 8.51, risk adjusted performance of (0.07), and Mean Deviation of 6.04. Cardio Diagnostics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Cardio Diagnostics Price Movement Analysis

Cardio Diagnostics Insider Trading Activities

Cardio Diagnostics Predictive Daily Indicators

Cardio Diagnostics Forecast Models

Cardio Diagnostics' time-series forecasting models are one of many Cardio Diagnostics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cardio Diagnostics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cardio Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cardio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cardio Diagnostics. By using and applying Cardio Stock analysis, traders can create a robust methodology for identifying Cardio entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cardio analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cardio analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Cardio Diagnostics Holdings stock analysis indicators help investors evaluate how Cardio Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cardio Diagnostics shares will generate the highest return on investment. By understating and applying Cardio Diagnostics stock analysis, traders can identify Cardio Diagnostics position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardio Diagnostics. If investors know Cardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Cardio Diagnostics is measured differently than its book value, which is the value of Cardio that is recorded on the company's balance sheet. Investors also form their own opinion of Cardio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Cardio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardio Diagnostics' market value can be influenced by many factors that don't directly affect Cardio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cardio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardio Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.